News about and goings on at FUSION GENOMICS:
Fusion makes the front page in molecular diagnostics section in Dec 01 issue of genomeweb.
The article, “Fusion Genomics Developing Infectious Disease Dx Using Synthetic Oligonucleotide Probes, NGS” is only available to paid subscribers.
The article summarizes Fusion’s history and talks about our ONETest platform and our ONETest PathoGenome which we are developing for diagnosing all 1400+ human pathogens using a single test.
One of Canada’s premier technology newsletters talks about how Fusion Genomics is on the forefront of global efforts to stop the next pandemic!
Financial Post talks to Fusion Genomics CEO Dr. Mohammed Qadir about Fusion’s efforts to “take undiagnosed out of the medical vocabulary”